← Back to Search

Daily Self-Weighing for Obesity Management (SWOP Trial)

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 19-65 years
Resides in one location at least 5 days each week
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 18 to month 24
Awards & highlights

SWOP Trial Summary

This trial will test whether daily self-weighing can help people with obesity prevent continued weight gain.

Who is the study for?
This trial is for adults aged 19-65 with obesity (BMI of 30-50) who are patients at participating clinics, live in one place most of the week, and have a smartphone with internet. It's not for those planning to move soon, who've lost significant weight recently or taken weight loss drugs, had bariatric surgery within two years, are pregnant or might become so during the study.Check my eligibility
What is being tested?
The trial tests if daily self-weighing using an electronic scale can help manage obesity in primary care settings. Participants will either receive standard care or be asked to weigh themselves every day to see if this prevents further weight gain.See study design
What are the potential side effects?
Since this intervention involves self-monitoring rather than medication, traditional side effects aren't expected. However, participants may experience psychological impacts such as stress or motivation changes due to regular weight tracking.

SWOP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 19 and 65 years old.
Select...
I stay in one place for most of the week.

SWOP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 18 to month 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 18 to month 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in body weight from baseline to month 12
Change in body weight from baseline to month 18
Change in body weight from baseline to month 24
+1 more
Secondary outcome measures
Average number of weight control behaviors endorsed on the Weight Control Practices Survey at month 12
Average number of weight control behaviors endorsed on the Weight Control Practices Survey at month 18
Average number of weight control behaviors endorsed on the Weight Control Practices Survey at month 24
+1 more
Other outcome measures
Healthcare utilization at month 12 assessed by the EuroQOL (EQ-5D-5L)
Healthcare utilization at month 24 assessed by the EuroQOL (EQ-5D-5L)
Mean score on the Body Shape Questionnaire-16A at month 12
+7 more

SWOP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Daily Self-WeighingExperimental Treatment1 Intervention
Participants randomly assigned to this arm will receive standardized weight management educational materials plus a commercially available wireless scale. Participants will be instructed to weigh daily and view their weight on the scale's digital display.
Group II: Standard CareActive Control1 Intervention
Participants randomly assigned to this arm will receive standardized weight management educational materials plus a monetary gift of $60 that can be used to purchase health-promoting supplies to support weight management.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,581 Previous Clinical Trials
2,277,633 Total Patients Enrolled
72 Trials studying Obesity
473,734 Patients Enrolled for Obesity
Indiana UniversityOTHER
980 Previous Clinical Trials
982,765 Total Patients Enrolled
12 Trials studying Obesity
2,235 Patients Enrolled for Obesity
Cornell UniversityOTHER
166 Previous Clinical Trials
14,089,464 Total Patients Enrolled
10 Trials studying Obesity
4,170 Patients Enrolled for Obesity

Media Library

Daily Self-Weighing Clinical Trial Eligibility Overview. Trial Name: NCT04044794 — N/A
Obesity Research Study Groups: Standard Care, Daily Self-Weighing
Obesity Clinical Trial 2023: Daily Self-Weighing Highlights & Side Effects. Trial Name: NCT04044794 — N/A
Daily Self-Weighing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04044794 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently participating in this research experiment?

"Affirmative, clinicaltrials.gov has the most up-to-date information on this medical trial's status and recruitment efforts. The study was initially posted in November of 2020 and it is actively recruiting 400 people at a single site as of March 2022."

Answered by AI

Can elderly individuals aged eighty and above participate in this scientific experiment?

"As articulated by the study's requirements, participants must be between 19 and 65 years old to be considered for enrollment."

Answered by AI

Is this experiment recruiting participants at the present time?

"According to information found on clinicaltrials.gov, the trial is currently open for enrollment, having been initially posted on November 4th 2020 and recently updated March 4th 2022."

Answered by AI

Am I eligible to participate in this experiment?

"The scope of this trial is to enroll 400 people who are struggling with obesity, between the ages 19-65. Furthermore, they must satisfy these additional prerequisites: BMI 30 - 50 kg/m2; primary care clinic attendance; home Wi-Fi or Bluetooth access and a smartphone with data service."

Answered by AI

What is the intended outcome of this medical experiment?

"The key objective of this medical experiment, which will be evaluated over a two-year period, is assessing the displacement in bodyweight from baseline to month 12. Secondary goals include determining patient's adherence to weight control practices such as decreasing fat intake and increasing physical activity at months 6 and 24, respectively, using a modified version of the 23-item Weight Control Practices Survey."

Answered by AI

Who else is applying?

What state do they live in?
Alabama
How old are they?
18 - 65
What site did they apply to?
University of Alabama at Birmingham
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2
3+
0

What questions have other patients asked about this trial?

How long do screening visits take?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

I am applying to this trial because I desperately need to lose weight for my health and wellbeing.
PatientReceived no prior treatments
I have been unable to motivate myself to lose weight. I am limited to exercise in that I have rheumatoid arthritis and broke my ankle last October.
PatientReceived 1 prior treatment
Recent research and studies
Contemporary Clinical TrialsJournal
The Daily Self-weighing for Obesity Management in Primary Care Study: Rationale, Design and Methodology
Dutton, Gareth R., Amber W. Kinsey, Carrie R. Howell, Maria Pisu, Amy E. Dobelstein, David B. Allison, Pengcheng Xun, David A. Levitsky, and Kevin Fontaine. 2021. “The Daily Self-weighing for Obesity Management in Primary Care Study: Rationale, Design and Methodology”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2021.106463.
clinicaltrials.govStudy
Daily Self-Weighing for Obesity Management in Primary Care
Gareth R. Dutton PhD 2020. "Daily Self-Weighing for Obesity Management in Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04044794.
~78 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top